CMV was implicated as a dominant driver of development of highly cytotoxic CD4+ T cells, as these cells were markedly enriched in CMV-seropositive individuals. This comprehensive phenotypic atlas of CD4 CTL advances our understanding of their development and highlights potential targets for diagnosing, treating, and preventing MS progression.
Hoeks et al. (Mon,) studied this question.